Erin Burkhart

GVP, Chief Accounting Officer, BioMarin Pharmaceutical.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 22, 2026Shares withheld for tax 768 shares at $152.67 of Gilead Sciences⁴
Sep 22, 2026Exercised options 2,223 shares of Gilead Sciences⁴
May 20, 2025Sold 1,786 shares at $59.31 of BioMarin Pharmaceutical³
May 19, 2025Shares withheld for tax 996 shares at $59.27 of BioMarin Pharmaceutical³
Mar 19, 2025Sold 1,295 shares at $71.52 of BioMarin Pharmaceutical⁵
Mar 17, 2025Granted 5,970 shares of BioMarin Pharmaceutical⁶
Mar 14, 2025Shares withheld for tax 823 shares at $69.44 of BioMarin Pharmaceutical⁶
Feb 24, 2025Sold 1,344 shares at $68.38 of BioMarin Pharmaceutical⁷
Aug 13, 2024Sold 714 shares at $90.00 of BioMarin Pharmaceutical⁸
May 17, 2024Shares withheld for tax 993 shares at $76.97 of BioMarin Pharmaceutical⁹
Apr 10, 2024Sold 2,286 shares at $90.00 of BioMarin Pharmaceutical¹⁰
Mar 18, 2024Shares withheld for tax 372 shares at $83.87 of BioMarin Pharmaceutical¹¹
Mar 15, 2024Granted 4,720 shares of BioMarin Pharmaceutical¹¹
May 16, 2023Shares withheld for tax 796 shares at $92.02 of BioMarin Pharmaceutical¹²
Mar 15, 2023Granted 3,760 shares of BioMarin Pharmaceutical¹³
May 16, 2022Granted 11,130 shares of BioMarin Pharmaceutical¹⁴

The numbers on this page point here. Each one links to the record it came from.